Acquisition aims to strengthen Merck's downstream process offering of advanced filtration and chromatography solutions
New results from telisotuzumab adizutecan (Temab-A) and ABBV-706 demonstrate continued progress in AbbVie's antibody-drug conjugate (ADC) portfolio targeting difficult-to-treat cancers
New test expands access to early Alzheimer’s assessment, streamlining diagnostic pathways and improving referral efficiency
The Cranbury facility represents a strategic advancement of the company's operations in the Unted States
The new data highlight the potential of AstraZeneca’s innovative therapies to improve outcomes across multiple cancer types
ExellenS applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed
Acquisition expands Novo Nordisk’s leadership in obesity-related comorbidities and metabolic diseases
The company will present new data from across over 20 cancer types and multiple treatment settings at European Society for Medical Oncology Congress 2025
PeptiGlow features premium-grade hydrolyzed collagen peptides that support skin elasticity and hydration
Subscribe To Our Newsletter & Stay Updated